THE CANADIAN PRESS
A new study finds promise in a drug associated with significantly reduced hospitalizations among high-risk patients who received an injection in the early stages of COVID-19 infection. Edward Mills, one of the authors, said peginterferon lambda stands out as a potential “one-and-done” treatment for older patients, noting current options include […]








